United Therapeutics Corp (UTHR)

Apr 16, 2025

United Therapeutics director Raymond Dwek sells $855,480 in stock - Investing.com Australia

Apr 16, 2025

Apr 16, 2025

United Therapeutics Schedules Key Q1 2025 Financial Results: What Pharma Investors Should Watch - Stock Titan

Apr 16, 2025

Apr 15, 2025

United Therapeutics director Raymond Dwek sells $855,480 in stock By Investing.com - Investing.com Canada

Apr 15, 2025

Apr 11, 2025

Here's Why United Therapeutics (UTHR) is a Strong Value Stock - Yahoo Finance

Apr 11, 2025

Apr 10, 2025

United Therapeutics director Raymond Dwek sells shares for $1.14 million - Investing.com Australia

Apr 10, 2025

Apr 08, 2025

United Therapeutics director Raymond Dwek sells shares for $1.14 million By Investing.com - Investing.com India

Apr 08, 2025

Apr 08, 2025

Will United Therapeutics (UTHR) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance

Apr 08, 2025

Apr 07, 2025

United Therapeutics EVP sells $3.37 million in stock By Investing.com - Investing.com Australia

Apr 07, 2025

Apr 07, 2025

United Therapeutics EVP sells $3.37 million in stock - Investing.com

Apr 07, 2025

Apr 07, 2025

Spotting Winners: United Therapeutics (NASDAQ:UTHR) And Therapeutics Stocks In Q4 - Yahoo Finance

Apr 07, 2025

Apr 04, 2025

Game-Changing Transplant Data: United Therapeutics Unveils 10 Major Studies at ISHLT 2025 - Stock Titan

Apr 04, 2025

Apr 02, 2025

Fortune Names This Innovative Biotech Among Best Companies to Work For in 2025 - Stock Titan

Apr 02, 2025

Apr 02, 2025

Is United Therapeutics Corporation (UTHR) The Most Profitable Biotech Stock To Buy Right Now? - Insider Monkey

Apr 02, 2025

Apr 02, 2025

United Therapeutics Co. (NASDAQ:UTHR) Shares Sold by Brandywine Global Investment Management LLC - MarketBeat

Apr 02, 2025

Apr 01, 2025

Korea Investment CORP Acquires 2,300 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Apr 01, 2025

Mar 31, 2025

Prudential Financial Inc. Buys 12,104 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Mar 31, 2025

Mar 29, 2025

United Therapeutics: Don't Fear The Patent Expiration Too Much (NASDAQ:UTHR) - Seeking Alpha

Mar 29, 2025

Mar 28, 2025

Is United Therapeutics (UTHR) The Most Expensive Stock Insiders Are Dumping In March? - Insider Monkey

Mar 28, 2025

Mar 28, 2025

United Therapeutics (UTHR) Down 4.8% Since Last Earnings Report: Can It Rebound? - Yahoo Finance

Mar 28, 2025

Mar 25, 2025

United Therapeutics director sells $796,990 in stock By Investing.com - Investing.com Australia

Mar 25, 2025

Mar 25, 2025

United Therapeutics director sells $796,990 in stock - Investing.com

Mar 25, 2025

Mar 24, 2025

First Week of November 21st Options Trading For United Therapeutics (UTHR) - Nasdaq

Mar 24, 2025

Mar 20, 2025

United Therapeutics director sells $1.55 million in stock By Investing.com - Investing.com Canada

Mar 20, 2025

Mar 20, 2025

United Therapeutics director sells $1.55 million in stock - Investing.com India

Mar 20, 2025

Mar 20, 2025

Market Turbulence? These 20 Stocks Boast a Perfect Piotroski Score and 40%+ Upside - Investing.com

Mar 20, 2025

Mar 19, 2025

United Therapeutics price target lowered to $314 from $328 at BofA - TipRanks

Mar 19, 2025

Mar 19, 2025

Exosome Therapy Market Market Is Booming Worldwide 2025-2032 | - openPR

Mar 19, 2025

Mar 14, 2025

Is United Therapeutics Corporation (UTHR) the Best Healthcare Stock For Long-Term Investment? - Insider Monkey

Mar 14, 2025

Mar 12, 2025

United Therapeutics president Michael Benkowitz sells $640k in stock By Investing.com - Investing.com Australia

Mar 12, 2025

Mar 11, 2025

For patients needing transplants, hope arrives on tiny hooves - The Spokesman Review

Mar 11, 2025

Mar 11, 2025

United Therapeutics president Michael Benkowitz sells $640k in stock - Investing.com

Mar 11, 2025

Mar 11, 2025

United Therapeutics at Leerink’s Global Healthcare Conference: Strategic Growth and Innovation - Investing.com

Mar 11, 2025

Mar 04, 2025

What Will United Therapeutics Reveal at the Leerink Conference? Key Details for Investors - StockTitan

Mar 04, 2025

Mar 03, 2025

Top Executives Cash In on United Therapeutics Stock! - TipRanks

Mar 03, 2025

Mar 03, 2025

Ray Kurzweil Sells 15,000 Shares of United Therapeutics Corp - GuruFocus.com

Mar 03, 2025

Mar 03, 2025

United Therapeutics director Thompson sells $795,837 in stock By Investing.com - Investing.com Canada

Mar 03, 2025

Mar 03, 2025

United Therapeutics director Thompson sells $795,837 in stock - Investing.com India

Mar 03, 2025

Mar 03, 2025

Silver Spring's United Therapeutics to Begin Clinical Study of Groundbreaking UKidney™ (Pig Organ) Transplant - The MoCoShow

Mar 03, 2025

Mar 03, 2025

Q2 EPS Estimate for United Therapeutics Lowered by Analyst - Defense World

Mar 03, 2025

Mar 01, 2025

Oppenheimer Asset Management Inc. Sells 6,988 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Mar 01, 2025

Mar 01, 2025

Bank of New York Mellon Corp Sells 1,693 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Mar 01, 2025

Mar 01, 2025

United Therapeutics Receives FDA Approval for Pig Organ Clinical Trials - Source of the Spring

Mar 01, 2025

Mar 01, 2025

United Therapeutics (NASDAQ:UTHR) Earns “Buy” Rating from HC Wainwright - Defense World

Mar 01, 2025

Mar 01, 2025

United Therapeutics Co. (NASDAQ:UTHR) Shares Sold by New York State Common Retirement Fund - MarketBeat

Mar 01, 2025

Feb 28, 2025

Weil Company Inc. Has $449,000 Position in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Feb 28, 2025

Feb 28, 2025

United Therapeutics (NASDAQ:UTHR) Releases Earnings Results, Beats Expectations By $0.09 EPS - MarketBeat

Feb 28, 2025